IndiPharm is a Clinical Development Organization, headquartered in the United States, with clinical and administrative operations in Malaysia and India.  IndiPharm’s experienced management team, U.S.-based client services, strong global SOPs, well-trained medical professional staff, and deep understanding of the local culture and regulatory system, facilitates the delivery of high-quality clinical trials with lower costs, faster recruitment, and better quality outcomes - all while meeting development milestones. All operational activities meet or exceed FDA/EMA/ICH standards.

Our mission is to help clients bring new and better therapeutics to the market faster by providing an efficient and highly effective gateway to clinical research in Asia at the “lowest total delivered cost” without any sacrifice to quality or outcomes. This translates to more control, better communication, and higher quality results for clinical research in Asia and around the world.